Hyperparathyroidism News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Hyperparathyroidism In Dogs: Symptoms, Causes, & Treatments - DogTime



DogTime
 
Hyperparathyroidism In Dogs: Symptoms, Causes, & Treatments 
DogTime
Hyperparathyroidism in dogs is a condition that happens when the parathyroid glands produce unusually high levels of parathyroid hormone (PTH), which results in an increase in blood calcium levels. Normally, the parathyroid glands maintain calcium and ...

 


Hyperparathyroidism Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - PR Newswire (press release)



Hyperparathyroidism Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 
PR Newswire (press release)
LONDON, Oct. 25, 2017 /PRNewswire/ -- Hyperparathyroidism clinical trials report from VPA Research provides comprehensive analysis and trends in global Hyperparathyroidism disease clinical trials. The research work analyzes the evolution of ...

and more » 


Secondary Hyperparathyroidism Treatment Market Estimated to Flourish by 2025 - MilTech



Secondary Hyperparathyroidism Treatment Market Estimated to Flourish by 2025 
MilTech
In Secondary hyperparathyroidism, the parathyroid glands overproduce the parathyroid hormone to help the body to increase the content of calcium in the blood. The parathyroid glands only have a job to maintain the calcium levels in the blood, and the ...

 


Sporadic Primary Hyperparathyroidism and Stone Disease: a Comprehensive Metabolic Evaluation Before and After ... - UroToday



Sporadic Primary Hyperparathyroidism and Stone Disease: a Comprehensive Metabolic Evaluation Before and After ... 
UroToday
to characterize the stone risk and the impact of parathyroidectomy on the metabolic profile of patients with primary hyperparathyroidism (PHPT) and urolithiasis. We analyzed the prospectively collected charts of patients treated at our stone clinic ...

 


Hyperparathyroidism Global Clinical Trials Review, H2, 2017 - PR Newswire (press release)



Hyperparathyroidism Global Clinical Trials Review, H2, 2017 
PR Newswire (press release)
GlobalData's clinical trial report, "Hyperparathyroidism Global Clinical Trials Review, H2, 2017" provides an overview of Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on ...

and more » 


Cerebrovascular Dysfunction May Affect Cognition in Primary Hyperparathyroidism - Psychiatry Advisor



Psychiatry Advisor
 
Cerebrovascular Dysfunction May Affect Cognition in Primary Hyperparathyroidism 
Psychiatry Advisor
Primary hyperparathyroidism (PHPT) may be linked to lower intracerebral vasomotor reactivity (VMR), which may result in cognitive dysfunction, according to study results presented at the American Society for Bone and Mineral Research (ASBMR) 2017 ...

 


Parathyroidectomy May Improve SHPT Patient Survival - Renal and Urology News



Renal and Urology News
 
Parathyroidectomy May Improve SHPT Patient Survival 
Renal and Urology News
ESRD patients with SHPT undergoing surgery had a 26% lower risk for all-cause mortality compared with medical management. Patients with secondary hyperparathyroidism (SHPT) might live longer by undergoing parathyroidectomy, a new systematic ...

 


Hyperparathyroidism Analysis by Stage of Development, Route of Administration, and Molecule Type - Medgadget (blog)



Hyperparathyroidism Analysis by Stage of Development, Route of Administration, and Molecule Type 
Medgadget (blog)
?Hyperparathyroidism-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Hyperparathyroidism. The report provides a complete understanding of the pipeline activities ...

and more » 


No iPTH Oversuppression With Extended-Release Calcifediol - Renal and Urology News



Renal and Urology News
 
No iPTH Oversuppression With Extended-Release Calcifediol 
Renal and Urology News
NEW ORLEANS?Extended-release calcifediol (ERC) reduces intact parathyroid hormone (iPTH) levels gradually, according to secondary hyperparathyroidism (SHPT) severity, with no evidence of oversuppression, researchers reported at the American ...

 


Rockwell Medical Schedules Third Quarter 2017 Earnings Call - GlobeNewswire (press release)



BangaloreWeekly
 
Rockwell Medical Schedules Third Quarter 2017 Earnings Call 
GlobeNewswire (press release)
Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and ...
Rockwell Medical (RMTI) Analysts See $-0.10 EPS; Pingtan Marine Enterprise LTD (CGEIU)'s Sentiment Is 0.67 Key Gazette

all 18 news articles »